Literature DB >> 7551004

Primary osteosarcoma arising from cirrhotic liver.

Y Kitayama1, H Sugimura, T Arai, K Nagamatsu, I Kino.   

Abstract

An autopsy case of a 67 year old man with primary osteosarcoma arising in cirrhotic liver is reported. His son had von Recklinghausen disease and he had had a history of hepatitis C virus infection for 10 years. A large tumor, about 10 cm in diameter, was found in the right liver lobe. This tumor showed marked central necrosis and hemorrhage, and histologically diffuse sarcomatous cell proliferation associated with extensive osteoid formation and calcification of the periphery. Examination of the whole tumor and the cirrhotic liver (155 tissue blocks) showed that the tumor consisted of sarcoma cells mixed with osteoid with no region resembling hepatocellular carcinoma or hepatoblastoma. Minute hepatocellular carcinomas were found in the cirrhotic liver distant from the sarcomatous area. On immunohistochemical examination, the main tumor gave a distinct positive reaction for vimentin, but not for keratin or other epithelial markers. These findings indicate that the tumor was a true primary osteosarcoma, not an osteoid metaplasia of hepatocellular carcinoma.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7551004     DOI: 10.1111/j.1440-1827.1995.tb03464.x

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  3 in total

Review 1.  Primary Osteosarcoma of the Liver: Case Report and Literature Review.

Authors:  Lu Yu; Shou Jing Yang
Journal:  Pathol Oncol Res       Date:  2018-10-25       Impact factor: 3.201

2.  Primary Hepatic Osteosarcoma: A Rare Cause of Primary Liver Tumor.

Authors:  Tsering Gyalpo Lama Tamang; Marina Shuster; Abhinav B Chandra
Journal:  Clin Med Insights Case Rep       Date:  2016-04-10

3.  Primary hepatic osteosarcoma.

Authors:  Atta Nawabi; Sidhartha Rath; Nicholas Nissen; Charles Forscher; Steven Colquhoun; Joseph Lee; Stephen Geller; Anna Wong; Andrew S Klein
Journal:  J Gastrointest Surg       Date:  2009-03-18       Impact factor: 3.452

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.